Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Nordic Bioscience specializes in developing and providing extracellular matrix-based protein biomarker assays used by pharmaceutical companies to accelerate preclinical and clinical drug development. Their technology enables precision medicine approaches by quantifying disease activity through blood-based markers of tissue remodeling. They have over three decades of experience, more than one hundred unique biomarkers developed, three FDA validated markers, over seven hundred fifty scientific publications, CAP/CLIA-accredited labs, and global partnerships with leading pharma companies.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Nordic Bioscience.